These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38246870)

  • 1. Protein-Templated Ugi Reactions versus In-Situ Ligation Screening: Two Roads to the Identification of SARS-CoV-2 Main Protease Inhibitors.
    Wamser R; Zhang X; Kuropka B; Arkona C; Rademann J
    Chemistry; 2024 Mar; 30(17):e202303940. PubMed ID: 38246870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Still Unconquered: Enantioselective Passerini and Ugi Multicomponent Reactions.
    Wang Q; Wang DX; Wang MX; Zhu J
    Acc Chem Res; 2018 May; 51(5):1290-1300. PubMed ID: 29708723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy.
    Mohammad T; Shamsi A; Anwar S; Umair M; Hussain A; Rehman MT; AlAjmi MF; Islam A; Hassan MI
    Virus Res; 2020 Oct; 288():198102. PubMed ID: 32717346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved fluorescence-based assay for rapid screening and evaluation of SARS-CoV-2 main protease inhibitors.
    Zhang R; Yan H; Zhou J; Yan G; Liu X; Shang C; Chen Y
    J Med Virol; 2024 Mar; 96(3):e29498. PubMed ID: 38436148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Discovery of SARS-CoV-2 main protease inhibitors using an optimized FRET-based high-throughput screening assay].
    Yan G; Li D; Qi H; Fu Z; Liu X; Zhang J; Chen Y
    Sheng Wu Gong Cheng Xue Bao; 2022 Jun; 38(6):2236-2249. PubMed ID: 35786475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-crystallization and structure determination: An effective direction for anti-SARS-CoV-2 drug discovery.
    Wang Z; Yang L; Zhao XE
    Comput Struct Biotechnol J; 2021; 19():4684-4701. PubMed ID: 34426762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2.
    Olubiyi OO; Olagunju M; Keutmann M; Loschwitz J; Strodel B
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32668701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (M
    Hicks EG; Kandel SE; Lampe JN
    Bioorg Med Chem Lett; 2022 Jun; 66():128732. PubMed ID: 35427739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-Templated Hit Identification through an Ugi Four-Component Reaction*.
    Mancini F; Unver MY; Elgaher WAM; Jumde VR; Alhayek A; Lukat P; Herrmann J; Witte MD; Köck M; Blankenfeldt W; Müller R; Hirsch AKH
    Chemistry; 2020 Nov; 26(64):14585-14593. PubMed ID: 32428268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iterated Virtual Screening-Assisted Antiviral and Enzyme Inhibition Assays Reveal the Discovery of Novel Promising Anti-SARS-CoV-2 with Dual Activity.
    Hamdy R; Fayed B; Mostafa A; Shama NMA; Mahmoud SH; Mehta CH; Nayak Y; M Soliman SS
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors.
    Ibrahim MAA; Abdelrahman AHM; Hussien TA; Badr EAA; Mohamed TA; El-Seedi HR; Pare PW; Efferth T; Hegazy MF
    Comput Biol Med; 2020 Nov; 126():104046. PubMed ID: 33065388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abietic, maleopimaric and quinopimaric dipeptide Ugi-4CR derivatives and their potency against influenza A and SARS-CoV-2.
    Tretyakova EV; Ma X; Kazakova OB; Shtro AA; Petukhova GD; Smirnova AA; Xu H; Xiao S
    Nat Prod Res; 2023 Jun; 37(12):1954-1960. PubMed ID: 35975755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
    Goyal B; Goyal D
    ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.
    Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A
    PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel
    Sencanski M; Perovic V; Pajovic SB; Adzic M; Paessler S; Glisic S
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32842509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyzing 3D structures of the SARS-CoV-2 main protease reveals structural features of ligand binding for COVID-19 drug discovery.
    Xu L; Chen R; Liu J; Patterson TA; Hong H
    Drug Discov Today; 2023 Oct; 28(10):103727. PubMed ID: 37516343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical screening for SARS-CoV-2 main protease inhibitors.
    Coelho C; Gallo G; Campos CB; Hardy L; Würtele M
    PLoS One; 2020; 15(10):e0240079. PubMed ID: 33022015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient discovery of potential inhibitors for SARS-CoV-2 3C-like protease from herbal extracts using a native MS-based affinity-selection method.
    Zhu D; Su H; Ke C; Tang C; Witt M; Quinn RJ; Xu Y; Liu J; Ye Y
    J Pharm Biomed Anal; 2022 Feb; 209():114538. PubMed ID: 34929567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.